Hemophagocytic Lymphohistiocytosis Treatment Market Addressing Rare but Life-Threatening Immune Dysregulation
Market Overview The hemophagocytic lymphohistiocytosis treatment market serves a rare but devastating condition characterized by uncontrolled immune activation, macrophage proliferation, and multi-organ failure that claims lives without prompt diagnosis and aggressive immunosuppressive therapy. HLH can be familial with genetic mutations affecting cytotoxic lymphocyte function or secondary to...
0 Comments 0 Shares 111 Views 0 Reviews